MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment. [electronic resource]
Producer: 20210923Description: 2297-2312 p. digitalISSN:- 1476-5403
- Antimitotic Agents -- pharmacology
- Caspases -- metabolism
- Cell Cycle Checkpoints -- drug effects
- Cell Death -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Enzyme Activation -- drug effects
- Humans
- Membrane Proteins -- metabolism
- Myeloid Cell Leukemia Sequence 1 Protein -- metabolism
- Protein Binding -- drug effects
- Protein Stability -- drug effects
- Proteolysis -- drug effects
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Ubiquitin-Protein Ligases -- metabolism
- Ubiquitination -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.